HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuma Yamakawa Selected Research

Dacarbazine (DIC)

6/2022Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study.
6/2022Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives".
1/2022Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
1/2021Recombinant Thrombomodulin in Disseminated Intravascular Coagulation Associated with Stage IV Solid Tumors: A Nationwide Observational Study in Japan.
1/2021Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation.
1/2021Pathophysiology of Coagulopathy Induced by Traumatic Brain Injury Is Identical to That of Disseminated Intravascular Coagulation With Hyperfibrinolysis.
1/2021Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients.
10/2020Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan.
10/2020Underlying Disorders, Clinical Phenotypes, and Treatment Diversity among Patients with Disseminated Intravascular Coagulation.
9/2020Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuma Yamakawa Research Topics

Disease

63Sepsis (Septicemia)
01/2022 - 01/2011
41Disseminated Intravascular Coagulation
06/2022 - 01/2011
17Wounds and Injuries (Trauma)
11/2021 - 05/2011
15Septic Shock (Toxic Shock Syndrome)
08/2021 - 01/2016
13Thrombosis (Thrombus)
06/2022 - 01/2011
13Hemorrhage
11/2021 - 04/2013
8Infections
01/2022 - 11/2011
8Critical Illness (Critically Ill)
01/2021 - 06/2015
7Inflammation (Inflammations)
01/2021 - 06/2012
6COVID-19
01/2022 - 09/2020
4Pneumonia (Pneumonitis)
01/2022 - 05/2011
4Neoplasms (Cancer)
01/2021 - 09/2020
4Multiple Organ Failure (MODS)
01/2021 - 06/2012
3Ventilator-Associated Pneumonia
01/2022 - 01/2017
2Communicable Diseases (Infectious Diseases)
01/2022 - 01/2017
2Muscular Diseases (Myopathy)
01/2021 - 01/2020
2Leukemia
10/2020 - 10/2020
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2017 - 07/2015
2Crush Injuries
12/2016 - 06/2012
1Gram-Negative Bacterial Infections
12/2021
1Bacteriuria
12/2021
1Seizures (Absence Seizure)
11/2021
1Hyperglycemia
10/2021
1Frailty
08/2021
1Acute Liver Failure (Fulminant Hepatic Failure)
07/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2021
1Lung Injury
07/2021
1Burns
01/2021
1Exsanguination
01/2021
1Shock
01/2021
1Pancreatitis
10/2020
1Aortic Diseases
10/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
09/2020
1Diabetes Mellitus
01/2020

Drug/Important Bio-Agent (IBA)

40Dacarbazine (DIC)FDA LinkGeneric
06/2022 - 01/2011
15AnticoagulantsIBA
01/2022 - 01/2011
14ThrombomodulinIBA
01/2022 - 01/2011
11Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2013
10AntithrombinsIBA
01/2022 - 01/2016
7Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2011
4Fibrinogen (Factor I)FDA Link
03/2021 - 02/2019
3Coloring Agents (Dyes)IBA
01/2022 - 01/2017
3Oxygen (Dioxygen)IBA
01/2022 - 01/2021
3Tranexamic Acid (AMCA)FDA Link
11/2021 - 01/2017
3fibrin fragment D (D-dimer)IBA
01/2021 - 02/2019
2Histones (Histone)IBA
06/2022 - 01/2016
2Proteins (Proteins, Gene)FDA Link
06/2022 - 06/2012
2HMGB1 Protein (HMG1)IBA
06/2022 - 06/2012
2FibrinIBA
06/2022 - 09/2020
2Pharmaceutical PreparationsIBA
01/2021 - 01/2021
2ConnectinIBA
01/2021 - 01/2020
2remdesivirIBA
01/2021 - 01/2021
2favipiravirIBA
01/2021 - 01/2021
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 01/2021
2tocilizumab (atlizumab)FDA Link
01/2021 - 01/2021
2Polymyxin B (Aerosporin)FDA LinkGeneric
11/2020 - 04/2017
2EndotoxinsIBA
11/2020 - 06/2013
2Hemostatics (Antihemorrhagics)IBA
09/2020 - 03/2016
2Plasminogen Activators (Plasminogen Activator)IBA
09/2020 - 01/2020
2SteroidsIBA
01/2020 - 11/2011
2Heparin (Liquaemin)FDA LinkGeneric
11/2019 - 01/2016
2ProcalcitoninIBA
01/2019 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 06/2012
2Receptor for Advanced Glycation End ProductsIBA
01/2017 - 06/2012
1SuspensionsIBA
01/2022
1beta-Lactamases (beta-Lactamase)IBA
12/2021
1Indicators and Reagents (Reagents)IBA
12/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2021
1nintedanibIBA
07/2021
1Immunoglobulin Fab FragmentsIBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021
1formycin diphosphate (FDP)IBA
01/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1baricitinibIBA
01/2021
1CatecholaminesIBA
01/2021
1Vasopressins (Vasopressin)IBA
01/2021
1casirivimab and imdevimab drug combinationIBA
01/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021
1antithrombin III-protease complexIBA
09/2020
1plasmin-plasmin inhibitor complexIBA
09/2020
1Amino AcidsFDA Link
01/2020
1Blood Glucose (Blood Sugar)IBA
01/2020

Therapy/Procedure

28Therapeutics
01/2022 - 01/2011
10Critical Care (Surgical Intensive Care)
08/2021 - 05/2011
8Resuscitation
01/2021 - 01/2017
5Mechanical Ventilators (Ventilator)
01/2021 - 05/2012
3Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2021
3Length of Stay
08/2021 - 10/2020
2Patient Care Bundles
01/2022 - 11/2019
2Hemoperfusion
11/2020 - 04/2017
2Patient Transfer (Patient Dumping)
01/2019 - 01/2018
2Intravenous Administration
01/2017 - 06/2012
1Punctures
01/2022
1Nutrition Therapy (Medical Nutrition Therapy)
01/2022
1Intraperitoneal Injections
01/2022
1Ligation
01/2022
1Glycemic Control
10/2021
1Blood Transfusion (Blood Transfusions)
03/2021
1Cell Transplantation
01/2021
1Transplantation
01/2021